
About Arkas Pharma Private Limited
Data last updated:
Arkas Pharma Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 12 December 2013 and has been in existence for over 13 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24232TG2013PTC091634. Its GSTIN is 36AAMCA2545D1ZV (Telangana).
The company has an authorised share capital of ₹50 Lakh and a paid-up capital of ₹40 Lakh. It is led by directors including Swapna Gorantla and Anil Kumar Gorantla.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2024. The registered office is at H.No.1 – 4 – 180/80/A Sai Baba Officers Colony Sainikpuri Kapra, Hyderabad, Telangana, India – 500094.
As per the financials filed for FY 2024, the company reported a revenue of ₹12.05 Cr, a growth of 1% compared to the previous year. For the same year it recorded a net profit of ₹81.31 Lakh (net margin 6.8%) and EBITDA of ₹1.1 Cr (EBITDA margin 9.1%). Revenue has grown at a compounded annual rate (CAGR) of 12% over three years and 16% over five years.
The company is associated with 1 brand: Arkas Pharma. The company has 3 deals on record (2 secondary share transfers, 1 funding round), with disclosed funding of ₹39 Lakh; the latest was in March 2016. Its 6 peer companies in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading) are compared by revenue, 3 larger and 3 smaller; the largest is Shilasagaram Enterprises Private Limited with revenue of ₹12.18 Cr.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website arkaspharma.com.
Company details
CIN history
Arkas Pharma has one previous CIN (Corporate Identification Number): U24232AP2013PTC091634. The current CIN is U24232TG2013PTC091634, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24232TG2013PTC091634 | Current |
| U24232AP2013PTC091634 | Previous |
Contact details
Arkas Pharma Private Limited's registered office is in Hyderabad, Telangana. Its website is arkaspharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressH.No.1 – 4 – 180/80/A Sai Baba Officers Colony Sainikpuri Kapra, Hyderabad, Telangana, India – 500094
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Arkas Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Arkas Pharma operates one associated brand: Arkas Pharma. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Pharmaceutical manufacturing and services focusing on medicines for cardiology, diabetes, and other categories in India. | arkaspharma.com |
Business activity
The main business activity of Arkas Pharma is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Arkas Pharma Private Limited, buy the company report.
Financials of Arkas Pharma Private Limited
FY 2024 filings availableArkas Pharma Private Limited reported revenue of ₹12.05 Cr (up 1% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 16% over five years, including 1% growth in the latest year. EBITDA rose 3% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.1 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹81.31 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 9.1% | ||||
| Net Profit Margin | 6.8% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Arkas Pharma Private Limited, buy the company report.
Board of directors of Arkas Pharma Private Limited
Arkas Pharma has 3 current directors and 6 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Swapna Gorantla | Director | 12 Dec 2013 | 12 Years 11 Months | Current |
| Anil Kumar Gorantla Also directs: Arkas CV Private Limited, Arkas Pharma Impex Private Limited | Director | 15 Nov 2014 | 12 Years 0 Months | Current |
| Raja Shekar Also directs: Arkas CV Private Limited | Director | 11 Jun 2020 | 6 Years 5 Months | Current |
Peer comparison
Arkas Pharma Private Limited is compared with the 6 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Shilasagaram Enterprises Private Limited | ₹12.18 Cr (FY 2024) | -9.0% | Hyderabad, Telangana, India | |||
| Slava Therapeutics Private Limited | ₹12.14 Cr (FY 2020) | 138.0% | Hyderabad, Telangana, India | |||
| Nandan Pharma Private Limited | ₹12.12 Cr (FY 2024) | 8.0% | Thane, Maharashtra, India | |||
| Arkas Pharma Private Limitedthis company | ₹12.05 Cr (FY 2024) | ₹81.31 Lakh | 6.8% | 1.0% | Hyderabad, Telangana, India | |
| Originix Healthcare Private Limited | ₹12.03 Cr (FY 2020) | -17.0% | Hyderabad, Telangana, India | |||
| Eyeskape Medicals Private Limited | ₹12.03 Cr (FY 2024) | -5.0% | Mumbai, Maharashtra, India | |||
| Trivio Healthcare Private Limited | ₹12.03 Cr (FY 2025) | 64.0% | Gujarat, India |
To see the full peer comparison of Arkas Pharma Private Limited, buy the company report.
Auditor
Arkas Pharma Private Limited is audited by THIRUPATHI & ASSOCIATES for the financial year 2020.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| THIRUPATHI & ASSOCIATES | FY 2020 | 013000S |
Shareholding
The shareholding of Arkas Pharma Private Limited is on record for 4 financial years, the latest being FY 2020, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2020 | FY 2019 | FY 2017 | FY 2016 |
|---|---|---|---|---|
| Promoters | ||||
| Domestic institutional investors (DII) | ||||
| Foreign institutional investors (FII) | ||||
| Public | ||||
| Others |
To see the full shareholding pattern of Arkas Pharma Private Limited, buy the company report.
Deals & funding
Arkas Pharma Private Limited has 3 deals on record (2 secondary share transfers, 1 funding round), with disclosed funding of ₹39 Lakh; the latest was in March 2016.
Deals on record (3 of 3)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Mar 2016 | Funding round | ₹39 Lakh | Investors: 4 individuals |
| Jul 2014 | Secondary share transfer | Undisclosed | Buyer: 2 individuals Seller: 2 individuals |
| Dec 2013 | Secondary share transfer | Undisclosed | Buyer: 2 individuals Seller: 3 individuals |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
No court or tribunal cases involving Arkas Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Arkas Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Arkas Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AAMCA2545D1ZV | Telangana | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Arkas Pharma Private Limited, buy the company report.
Recent activity
Arkas Pharma Private Limited has 9 board changes on record since 2013: 3 appointments and 6 cessations. The latest: Muppiri Shetty Santosh Kumar ceased to be Director on 02 Oct 2023.
Frequently asked questions
Arkas Pharma is an active private limited company based in Hyderabad, Telangana, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 12 December 2013 (13+ years old) and is registered under CIN U24232TG2013PTC091634.
Arkas Pharma has 3 current directors:
- Swapna Gorantla - Director
- Anil Kumar Gorantla - Director
- Raja Shekar - Director
The latest financial statements of Arkas Pharma on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Arkas Pharma is 36AAMCA2545D1ZV, registered in Telangana.
The CIN (Corporate Identification Number) of Arkas Pharma is U24232TG2013PTC091634. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Arkas Pharma was incorporated on 12 December 2013, making it 13+ years old. It is registered with the Registrar of Companies, Hyderabad.
Arkas Pharma has 3 deals on record (2 secondary share transfers, 1 funding round), with disclosed funding of ₹39 Lakh; the latest was in March 2016.
The peers of Arkas Pharma by revenue are Shilasagaram Enterprises Private Limited, Slava Therapeutics Private Limited, Nandan Pharma Private Limited, Originix Healthcare Private Limited, Eyeskape Medicals Private Limited and 1 more, all in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading).
Muppiri Shetty Santosh Kumar ceased to be Director on 02 Oct 2023. Raja Shekar was appointed as Director on 11 Jun 2020. Anil Kumar Gorantla ceased to be Additional Director on 29 Sep 2015. Arkas Pharma has 9 board changes on record in total.
Arkas Pharma can be reached through the website arkaspharma.com. Its registered office is in Hyderabad, Telangana, India.
The registered office of Arkas Pharma is at H.No.1 – 4 – 18080A Sai Baba Officers Colony Sainikpuri Kapra, Hyderabad, Telangana, India – 500094.

